CMS Interested In Part D Plan Collaboration With Medicare ACOs
This article was originally published in The Pink Sheet Daily
In a draft version of its annual instructions to Part D plans, CMS says it is seeking feedback from Part D sponsors and other stakeholders on “possible strategies for achieving better coordination” between stand-alone Medicare Part D plans and accountable care organizations to improve pharmacy care.
You may also be interested in...
The collaboration could be an important step toward more firmly establishing the value of drug treatment in lowering overall medical spending, a key goal for biopharma manufacturers looking for ways to adapt to new patient care models.
Amid Uncertainties, Acorda Preps For Next Phase Of ACA: An Interview With Managed Markets Head Kent Rogers
With nine months to go before key aspects of the Affordable Care Act are implemented, Acorda Therapeutics’ head of managed markets, Kent Rogers, says he, like everyone, is ‘learning.” Acorda expects to have a game plan ready by mid-summer on how it will adapt its commercial strategy to ACA-initiated changes. Rogers also points out that the company may be less affected than others in the near term because Medicare already covers the majority of patients who take its multiple sclerosis drug Ampyra.
The Marshfield Clinic in Wisconsin shows how pharmacists and health information technology can be incorporated into an accountable care organization’s pharmaceutical care in a way that can help improve patient outcomes and influence prescribing behavior.